To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Coronavirus: Vaccination
Thursday 29th April 2021

Asked by: Lord Moonie (Non-affiliated - Life peer)

Question to the Department for Business, Energy and Industrial Strategy:

To ask Her Majesty's Government, further to the Written Answer by Lord Callanan on 4 February (HL12442), which COVID-19 vaccines they have ordered to date by (1) manufacturer, (2) number of doses ordered, and (3) expected date of delivery.

Answered by Lord Callanan - Shadow Minister (Foreign, Commonwealth and Development Office)

It has not proved possible to respond to this question in the time available before Prorogation. I will correspond directly with the noble Lord.

Written Question
Coronavirus: Vaccination
Thursday 4th February 2021

Asked by: Lord Moonie (Non-affiliated - Life peer)

Question to the Department for Business, Energy and Industrial Strategy:

To ask Her Majesty's Government what assessment they have made of the progress of trials of each of the COVID-19 vaccines for which they have placed orders; and when they expect to take delivery of the first doses of those vaccines.

Answered by Lord Callanan - Shadow Minister (Foreign, Commonwealth and Development Office)

The UK Government has secured early access to 407 million vaccine doses through agreements with seven separate vaccine developers. The Government is working closely with vaccine developers to monitor progress of clinical trials.

  • The Pfizer/BioNTech vaccine was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) and this vaccine is already being deployed in the UK.
  • The Oxford/AstraZeneca vaccine was approved by the MHRA and this vaccine is already being deployed in the UK.
  • The Moderna vaccine was approved by the MHRA. Supplies of this vaccine will begin to be delivered to the UK from the spring once Moderna expands its production capability.
  • The Janssen vaccine is currently in phase 3 clinical trials. If clinical trials prove the vaccine to be safe and effective, supplies of the vaccine could start to be delivered to the UK in the second half of 2021.
  • The Novavax vaccine is currently in phase 3 clinical trials. If clinical trials prove the vaccine to be safe and effective, supplies of the vaccine could start to be delivered to the UK in the second half of 2021.
  • The GlaxoSmithKline/SanofiPasteur vaccine is currently in phase 1/2 clinical trials. Deliveries of this vaccine are being discussed with the developer and dependent upon the vaccine being found to be safe and effective.
  • The Valneva vaccine is currently in phase 1/2 clinical trials. If clinical trials prove the vaccine to be safe and effective, supplies of the vaccine could be made available to the UK by the end of 2021.
Written Question
Energy: Conservation
Wednesday 19th October 2016

Asked by: Lord Moonie (Non-affiliated - Life peer)

Question to the Department for Business, Energy and Industrial Strategy:

To ask Her Majesty’s Government what steps they are taking to fill senior management vacancies on the Energy Savings Opportunity Scheme.

Answered by Baroness Neville-Rolfe - Shadow Minister (Treasury)

The Environment Agency (EA) has recently restructured its senior management team following a voluntary exit scheme and has filled all vacancies within the Energy Saving Opportunity Scheme (ESOS) senior team.

Written Question
Energy: Conservation
Wednesday 19th October 2016

Asked by: Lord Moonie (Non-affiliated - Life peer)

Question to the Department for Business, Energy and Industrial Strategy:

To ask Her Majesty’s Government what progress has been made in implementing Article 8(4–6) of the EU Energy Efficiency Directive (2012/27/EU) and the Energy Savings Opportunity Scheme Regulations 2014 which give effect to the scheme.

Answered by Baroness Neville-Rolfe - Shadow Minister (Treasury)

Article 8(4–6) of the EU Energy Efficiency Directive (2012/27/EU) came in to force in November 2012.

The Energy Saving Opportunity Scheme (ESOS) was developed and implemented as a result of this directive after consultation. The Regulations came into force in July 2014 and the Scheme was launched in July 2014. The Environment Agency acts as the Scheme Administrator on behalf of the Department for Business, Energy and Industrial Strategy.

The first Compliance deadline was in December 2015 and as of 10th October 6885 organisations have notified compliance. The Environment Agency and other regulators are now focussed on bringing remaining organisations into compliance with ESOS and preparing for the next compliance deadline in 2019.

Written Question
Renewable Energy: Feed-in Tariffs
Wednesday 12th October 2016

Asked by: Lord Moonie (Non-affiliated - Life peer)

Question to the Department for Business, Energy and Industrial Strategy:

To ask Her Majesty’s Government what plans they have to oblige electricity supply companies to forward feed-in tariff payments to small or domestic suppliers to a similar timescale as that which applies to small or domestic customers.

Answered by Baroness Neville-Rolfe - Shadow Minister (Treasury)

Payments to generators are based on generation meter readings and must be made at least quarterly. There is no restriction on FIT licensees making payments more frequently; generators may wish to consider this when choosing a FIT licensee or deciding to switch FIT licensees.